From Interferon Signature to the Clinical Landscape: Type I Interferonopathies - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Exploring Type I Interferonopathies: From Molecular Signatures to Clinical Implications

  • By

  • Ismail Yaz

  • Seza Ozen

  • Hacer N. Bildik

  • Canberk Ipsir

  • Dilara Unal

  • Saliha Esenboga

  • Begum Cicek

  • Mehmet E. Seker

  • Fatima Aerts-Kaya

  • Seher Sener

  • Mehmet O. Erkan

  • Hanife Avci

  • Deniz Cagdas

  • Ilhan Tezcan

  • June 22, 2026

Share

Original Source(s)

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

  • by Ismail Yaz, Seza Ozen, Hacer N. Bildik, Canberk Ipsir, Dilara Unal, Saliha Esenboga, Begum Cicek, Mehmet E. Seker, Fatima Aerts-Kaya, Seher Sener, Mehmet O. Erkan, Hanife Avci, Deniz Cagdas, Ilhan Tezcan

  • June 22, 2026

Related Content

Large language models provide unsafe answers to patient-posed medical questions

Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study

Case report: Pediatric vascular Behçet’s disease with prominent arterial involvement: a case series of five patients